RTHP-39. SINGLE ARM MULTI-CENTRIC PHASE II CLINICAL STUDY NAMED BORON NEUTRON CAPTURE THERAPY AND TEMOZOLOMIDE IN TREATING PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME

摘要

INTRODUCTIONWe have applied tumor-selective particle radiation boron neutron capture therapy (BNCT) to malignant brain tumors. Here we introduce the single arm, multi-centric phase II clinical study named “BNCT and Temozolomide in Treating Patients with Newly Diagnosed Glioblastoma Multiforme” (OSAKA-TRIBRAIN0902, ). MATERIALS AND